The diversion and injection of a buprenorphine-naloxone soluble film formulation
Briony Larance, Nicholas Lintzeris, Robert Ali, Paul Dietze, Richard Mattick, Rebecca Jenkinson, Nancy White, Louisa Degenhardt
Drug and Alcohol Dependence | ELSEVIER IRELAND LTD | Published : 2014
BACKGROUND: We compared the diversion and injection of a new formulation of buprenorphine, a buprenorphine-naloxone film product (BNX film), with buprenorphine-naloxone tablets (BNX tablets), mono-buprenorphine (BPN) and methadone (MET) in Australia. METHODS: Surveys were conducted with people who inject drugs regularly (PWID) (2004-2012) and opioid substitution treatment (OST) clients (2012, N=543). Key outcome measures: the unsanctioned removal of supervised doses, diversion, injection, motivations, drug liking and street price. Levels of injection among PWID were adjusted for background availability of medication using sales data. Doses not taken as directed by OST clients were adjusted b..View full abstract
These studies were funded by Reckitt Benckiser by way of an untied educational grant. This study's design, conduct and interpretation of findings are the work of the investigators. The funder played no role in the conception or writing of this paper.